Thu, March 15, 2018
Wed, March 14, 2018
Tue, March 13, 2018
Mon, March 12, 2018
Fri, March 9, 2018

David Nierengarten Maintained (SYRS) at Buy with Increased Target to $130 on, Mar 13th, 2018

David Nierengarten of Wedbush, Maintained "Syros Pharmaceuticals, Inc." (SYRS) at Buy with Increased Target from $110 to $130 on, Mar 13th, 2018.

David, nor any peers, have made any analyst calls on SYRS in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30